FDA approves quick malaria test

Jun 27, 2007

The U.S. Food and Drug Administration has approved the Binax NOW Malaria Test, the first rapid test authorized for laboratory use in the United States.

Standard laboratory tests for malaria require identifying parasites in a blood sample under a microscope -- a difficult task requiring training and experience.

The FDA said the new test is significantly faster and easier to use, producing results in 15 minutes after a few drops of whole blood are placed on a dipstick.

The test can also differentiate the most dangerous malaria parasite, Plasmodium falciparum, from less virulent malaria parasites. Results, however, still need to be confirmed using standard microscopic evaluation, the FDA noted.

Malaria was eliminated in the United States during the 1950s but citizens can become infected while traveling in other countries. There were 1,528 new U.S. cases of malaria reported during 2005, including seven deaths. The FDA said nearly all deaths can be prevented if the infection is diagnosed and treated early.

FDA scientists found the Binax NOW test was 95 percent accurate compared with standard microscopic diagnosis in a multi-center study.

The test is manufactured by Binax Inc., a subsidiary of Inverness Medical Innovations Inc.

Copyright 2007 by United Press International

Explore further: More than a quarter of emergency contraceptives in Peru falsified or substandard

add to favorites email to friend print save as pdf

Related Stories

Non-human sugar in biotech drugs causes inflammation

Jul 25, 2010

Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response ...

1930s drug slows tumor growth

Nov 06, 2009

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments : 0

More news stories

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.